Evidence map›Paper›PMID 26286516›Full record

ArticleBMC infectious diseases2015

Divergent cerebrospinal fluid cytokine network induced by non-viral and different viral infections on the central nervous system.

Michele Souza Bastos, Jordana Grazziela Coelho-Dos-Reis, Danielle Alves Gomes Zauli, Felipe Gomes Naveca, Rossicleia Lins Monte, João Paulo Pimentel, Valéria Munique Kramer Macário, Natália Lessa da Silva, Vanessa Peruhype-Magalhães, Marcelo Antônio Pascoal-Xavier and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Neuropsychiatric Disorders and COVID-19: What We Know So Far.Pharmaceuticals (Basel, Switzerland) · 2021
    Review
  5. Article
  6. Review
  7. COVID-19-Associated Acute Brain Dysfunction Related to Sepsis.Journal of clinical medicine research · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Michele Souza BastosTropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus, AM, Brazil. michelebastos01@gmail.com.
Jordana Grazziela Coelho-Dos-ReisLaboratory of Biomarkers for Diagnosis and Monitoring, René Rachou Research Center, FIOCRUZ, Av. Augusto de Lima 1715, Barro Preto, Belo Horizonte, Minas Gerais, CEP 30190-002, Brazil. jordana.reis@cpqrr.fiocruz.br.
Danielle Alves Gomes ZauliLaboratory of Biomarkers for Diagnosis and Monitoring, René Rachou Research Center, FIOCRUZ, Av. Augusto de Lima 1715, Barro Preto, Belo Horizonte, Minas Gerais, CEP 30190-002, Brazil. daniellezauli@yahoo.com.br.
Felipe Gomes NavecaInstitute Leônidas and Maria Deane - Fiocruz Amazônia, Manaus, AM, Brazil. fnaveca@amazonia.fiocruz.br.
Rossicleia Lins MonteTropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus, AM, Brazil. rossi@fmt.am.gov.br.
João Paulo PimentelHematology and Hemotherapic Foundation of Amazonas, Manaus, AM, Brazil. jpimentel@gmail.com.
Valéria Munique Kramer MacárioTropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus, AM, Brazil. muni_kramer@hotmail.com.
Natália Lessa da SilvaTropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus, AM, Brazil. naty_lessa@hotmail.com.
Vanessa Peruhype-MagalhãesLaboratory of Biomarkers for Diagnosis and Monitoring, René Rachou Research Center, FIOCRUZ, Av. Augusto de Lima 1715, Barro Preto, Belo Horizonte, Minas Gerais, CEP 30190-002, Brazil. vanessa@cpqrr.fiocruz.br.
Marcelo Antônio Pascoal-XavierDepartment of Anatomic Pathology, Medicine School, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil. mapx13@gmail.com.
Allyson GuimaraesHematology and Hemotherapic Foundation of Amazonas, Manaus, AM, Brazil. allyson.gui.costa@gmail.com.
Andréa Teixeira CarvalhoLaboratory of Biomarkers for Diagnosis and Monitoring, René Rachou Research Center, FIOCRUZ, Av. Augusto de Lima 1715, Barro Preto, Belo Horizonte, Minas Gerais, CEP 30190-002, Brazil. atcteixeira@gmail.com.
Adriana MalheiroHematology and Hemotherapic Foundation of Amazonas, Manaus, AM, Brazil. malheiroadriana@yahoo.com.br.
Olindo Assis Martins-FilhoLaboratory of Biomarkers for Diagnosis and Monitoring, René Rachou Research Center, FIOCRUZ, Av. Augusto de Lima 1715, Barro Preto, Belo Horizonte, Minas Gerais, CEP 30190-002, Brazil. oamfilho@cpqrr.fiocruz.br.
Maria Paula Gomes MourãoTropical Medicine Foundation Dr. Heitor Vieira Dourado, Manaus, AM, Brazil. mariapaula.mourao@gmail.com.
Fundação de Medicina Tropical · BRFundação Hospitalar de Hematologia e Hemoterapia do Amazonas · BRFundação Oswaldo Cruz · BRUniversidade Federal de Minas Gerais · BRCompanhia Energética de Minas Gerais (Brazil) · BRInstituto Nacional de Pesquisas da Amazônia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMeningoencephalitis is one of the most common disorders of the central nervous system (CNS) worldwide. Viral meningoencephalitis differs from bacterial meningitis in several aspects. In some developing countries, bacterial meningitis has appropriate clinical management and chemotherapy is available. Virus-associated and virus not detected meningoencephalitis are treatable, however, they may cause death in a few cases. The knowledge of how mediators of inflammation can induce disease would contribute for the design of affordable therapeutic strategies, as well as to the diagnosis of virus not detected and viral meningoencephalitis. Cytokine-induced inflammation to CNS requires several factors that are not fully understood yet.

methodsConsidering this, several cytokines were measured in the cerebrospinal fluid (CSF) of patients with undiagnosed and viral meningoencephalitis, and these were correlated with cellularity in the CSF.

resultsThe results demonstrate that an altered biochemical profile alongside increased cellularity in the cerebrospinal fluid is a feature of patients with meningoencephalitis that are not associated with the detection of virus in the CNS (P < 0.05). Moreover, HIV-positive patients (n = 10) that evolve with meningoencephalitis display a distinct biochemical/cytological profile (P < 0.05) in the cerebrospinal fluid. Meningoencephalitis brings about a prominent intrathecal cytokine storm regardless of the detection of virus as presumable etiological agent. In the case of Enterovirus infection (n = 13), meningoencephalitis elicits robust intrathecal pro-inflammatory cytokine pattern and elevated cellularity when compared to herpesvirus (n = 15) and Arbovirus (n = 5) viral infections (P < 0.05).

conclusionDifferences in the cytokine profile of the CSF may be unique if distinct, viral or presumably non-viral pathways initially trigger the inflammatory response in the CNS.

Indexed as

Arbovirus InfectionsCentral Nervous System Viral DiseasesCoinfectionCross-Sectional StudiesCytokinesDNA, ViralEnterovirus InfectionsHerpesviridae InfectionsHIV InfectionsHumansInflammationInterferon-gammaInterleukin-10Interleukin-12Interleukin-17Interleukin-6CytokinesDNA, ViralIL10 protein, humanIL17A protein, humanIL6 protein, humanInterferon-gammaInterleukin-10Interleukin-12Interleukin-17Interleukin-6RNA, ViralTumor Necrosis Factor-alpha

Identifiers

PMID26286516
PMCPMC4541733
OpenAlexW1935621105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.